Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting for allotment of Equity Shares on Preferential Basis

APTUS PHARMA LIMITED Date: 06th November 2026 The BSE Ltd Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001 SECURITY CODE: 544529 SCRIPT SYMBOL: APPL Subject: Intimation of Board Meeting for allotment of Equity Shares on Preferential Basis Dear Sir/Madam, Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 12th November, 2026, inter alia, to consider and approve the allotment of equity shares on a preferential basis to the proposed allottees, pursuant to the approval of shareholders at the Annual General Meeting held on 14th September, 2026, and the in-principle approval received from BSE Limited on 30th October, 2026, subject to receipt of subscription money and compliance with applicable statutory and regulatory requirements. Kindly take the above information on your record. Thanking you, Yours faithfully, For Aptus Pharma Limited Tejash Hathi Managing Director DIN: 03151221 Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM